IP Library › Assignment 024855/0508
Patent Assignment
Reel/Frame 024855/0508

Change of Name

Recorded: 2010-08-18 Pages: 4
Assignor
MYRIAD PHARMACEUTICALS, INC.
Executed: 2010-07-01
Assignee
MYREXIS, INC.
305 CHIPETA WAY, SALT LAKE CITY, UTAH, 84108
Covered Property (1)
4-Arylamino-Quinazolines and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent: 7,618,975 →
Application: 10/885,903 →
Publication: US 2005/0137213
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 20, 2004
From: PLEIMAN, CHRIS; BAICHWAL, VIJAY; MANFREDI, JOHN; BHOITE, LEENA
To: MYRIAD GENETICS, INC.
Reel/Frame 015151/0933 →
Assignment of Assignor's Interest Sep 20, 2004
From: CAI, SUI XIONG; SIRISOMA, NILANTHA SUDATH; PERVIN, AZRA; DREWE, JOHN A.
To: CYTOVIA, INC.
Reel/Frame 015152/0032 →
Assignment of Assignor's Interest Aug 6, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023061/0882 →
Security Agreement Feb 19, 2014
From: IMMUNE PHARMACEUTICALS INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 032277/0353 →
Release of Security Interest Aug 5, 2015
From: MIDCAP FINANCIAL TRUST
To: IMMUNE PHARMACEUTICALS, INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
Reel/Frame 036255/0778 →
Security Interest Oct 9, 2018
From: IMMUNE PHARMACEUTICALS INC.
To: DISCOVER GROWTH FUND, LLC
Reel/Frame 047107/0116 →